Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Clinical trial NCT01381861 · COMPLETED

Trial details

NCT number: NCT01381861
Sponsor: Tracon Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer Fallopian Tube Carcinoma Primary Peritoneal Carcinoma

Start date: 2011-07-01
Primary completion: 2012-08-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.